Skyrocketing prices for life-saving prescription drugs are a huge problem in health care. One of the worst examples which is getting lots of public attention right now is the EpiPen. Mylan, the maker of the most popular EpiPen in America, has raised prices on its EpiPens from around $100 for a pack of two to more than $600 per pack. Yet the cost to make EpiPens is just a few dollars. Despite media and public pressure, the company’s executives are not backing down and have given themselves millions of dollars in raises when implementing these unconscionable price hikes.